The present invention relates to novel heteroaryl diazacycloalkane derivatives which are found to be cholinergic ligands at the nicotinic Acetyl Choline Receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neurodegeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.

 
Web www.patentalert.com

< Implantable trial neurostimulation device

< Nucleic acids db, the receptor for leptin

> N-acylated lipophilic amino acid derivatives

> Pancreatic lipase inhibitor compounds, their synthesis and use

~ 00271